Please wait a minute...
文章检索
预防医学  2021, Vol. 33 Issue (5): 457-461    DOI: 10.19485/j.cnki.issn2096-5087.2021.05.006
  论著 本期目录 | 过刊浏览 | 高级检索 |
基于创新扩散理论的人乳头瘤病毒疫苗接种行为分析
朱义雯, 邓桢, 巴观平, 刘勇, 陈玉丰
杭州市西湖区北山街道社区卫生服务中心公共卫生管理科,浙江 杭州 310007
Analysis of HPV vaccination behavior based on diffusion of innovation
ZHU Yiwen, DENG Zhen, BA Guanping, LIU Yong, CHEN Yufeng
Xihu District Beishan Community Health Service Center, Hangzhou, Zhejiang 310000, China
全文: PDF(909 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 基于创新扩散理论分析人乳头瘤病毒(HPV)疫苗接种行为,为提高HPV疫苗接种意愿提供依据。方法 采用方便抽样法从杭州市2家社区卫生服务中心选择已预约或接种HPV疫苗至少1剂次的女性为调查对象,参考宫颈癌危险因素、HPV疫苗知识和接种时间设计问卷进行调查,基于创新扩散理论分析HPV疫苗接种扩散规律,分析不同扩散阶段的接种者的特征。结果 共纳入448人,年龄18~45岁,中位数为30.5岁。2017年4月以前为起步阶段,领头者8人,占1.79%;2017年10月—2018年2月为缓慢上升阶段,早期接种者59人,占13.17%;2018年4月—2019年4月为较快上升阶段,早期多数接种者160人,占35.71%;2019年5—8月为迅速上升阶段,后期多数接种者170人,占37.95%;2019年9月至调查结束日为滞缓阶段,落后者51人,占11.38%。领头者均接受宫颈癌筛查,均为自愿接种,均知晓宫颈癌易感人群、疫苗预防HPV型别和疫苗适用人群,妊娠3次6人,首次妊娠年龄中位数为27岁。早期接种者和早期多数接种者多因医生或朋友推荐而接种HPV疫苗,首次妊娠年龄中位数分别为26岁和28岁,其他特征与领头者基本相似。后期多数接种者和落后者特征相似,以学生,因朋友推荐而接种HPV疫苗,未接受宫颈癌筛查,不知晓宫颈癌易感人群、疫苗预防HPV型别和疫苗适用人群者居多。结论 暴露风险高、关注宫颈癌相关知识及接受筛查的人群早期接种HPV疫苗的可能性大。加强HPV疫苗接种健康教育,充分利用医生和早期接种者的意见领袖作用,有助于提高适龄人群HPV疫苗接种率。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
朱义雯
邓桢
巴观平
刘勇
陈玉丰
关键词 人乳头瘤病毒疫苗预防接种创新扩散理论    
AbstractObjective To understand the behavioral characteristics of vaccination of human papillomavirus (HPV) vaccine based on diffusion of innovation theory, and to put forward suggestions for improving the vaccination willingness. Methods The women who had made an appointment or received at least one dose of HPV vaccine in two community health service centers with HPV vaccination qualification in Hangzhou were recruited by convenience sampling method. A questionnaire survey was conducted according to cervical cancer risk factors, HPV vaccine knowledge and the time of vaccination. The diffusion of HPV vaccination and the characteristics of vaccinees in different stages was analyzed. Results A total of 448 women, aged from 18 to 45 years old, with a median of 30.5 years old, were investigated. The spread of HPV vaccine were divided into five stages: April 2017 and before was the initial stage, with 8 leaders, accounting for 1.79%; October 2017 to February 2018 was the slowly rising stage, with 59 early vaccinees, accounting for 13.17%; April 2018 to April 2019 was the rising stage, with 160 most early vaccinees, accounting for 35.71%; May to August 2019 was the rapidly rising stage, with 170 most late vaccinees, accounting for 37.95%; September 2019 to the end of the survey was the standstill stage, with 51 laggards, accounting for 11.38%. All of the leaders had participated in cervical cancer screening, voluntarily vaccinated, and knew the susceptible population of cervical cancer, the targeted HPV types and the suitable population of vaccine. The median age of the first pregnancy was 27 years old. Six of them had three pregnancies. The early vaccinees and the most early vaccinees were recommended by doctors or friends to get HPV vaccine. The median age of first pregnancy was 26 and 28 years old, respectively. Their other characteristics were similar to those of the leaders. The characteristics of most late vaccinees were similar to those of the laggards. They were were mainly students who were recommended by their friends to receive HPV vaccination, did not participate in cervical cancer screening, did not know the susceptible population of cervical cancer, the targeted HPV types and the suitable population of vaccine. Conclusions People with high risk of HPV exposure, awareness of cervical cancer and screening are more likely to receive HPV vaccination at the early stage. It is necessary to strengthen the health education of HPV vaccination, and make full use of the influence of doctors and early vaccinees, which is helpful to promote the early vaccination of HPV vaccine among the right age population.
Key wordshuman papilloma virus vaccine    vaccination    diffusion of innovation
收稿日期: 2020-10-12      修回日期: 2021-03-03      出版日期: 2021-05-10
中图分类号:  R186  
基金资助:杭州市卫生科技计划一般(B类) 项目(OO20191130)
通信作者: 朱义雯,E-mail:1018675104@qq.com   
作者简介: 朱义雯,本科,副主任护师,主要从事基层卫生工作
引用本文:   
朱义雯, 邓桢, 巴观平, 刘勇, 陈玉丰. 基于创新扩散理论的人乳头瘤病毒疫苗接种行为分析[J]. 预防医学, 2021, 33(5): 457-461.
ZHU Yiwen, DENG Zhen, BA Guanping, LIU Yong, CHEN Yufeng. Analysis of HPV vaccination behavior based on diffusion of innovation. Preventive Medicine, 2021, 33(5): 457-461.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2021.05.006      或      http://www.zjyfyxzz.com/CN/Y2021/V33/I5/457
[1] 陈韧炜. 人乳头瘤病毒与肿瘤[J].微生物与感染,2019,14(4):193-198.
[2] 赵方辉,张莉.预防性人类乳头瘤病毒疫苗开启了宫颈癌的全面防控时代[J].中华预防医学杂志,2019,53(1):10-12.
[3] GARLAND S M,PITISUTTITHUM P,NGAN H Y S.九价人乳头瘤病毒疫苗的保护效力、免疫原性和安全性:亚洲人群亚组分析[J]. 中国病毒病杂志,2018,8(4):336-342.
[4] 张继红,腾国伟,斗智,等.九价人乳头瘤病毒疫苗接种后保护效果、免疫原性及安全性meta分析[J].中国公共卫生,2019,35(4):491-496.
[5] 杨廷忠.健康研究:社会行为理论与方法[M].北京:人民卫生出版社,2017:80-88.
[6] 曹承建,李金涛,张琼,等.创新扩散理论在居民使用健康支持工具行为中的应用[J]. 中华预防医学杂志,2011,45(9):839-841.
[7] YANG T,COTTRELL R R,YANG X,et al.Commercial sex worker use among male Chinese rural-urban migrants[J]. Am J Health Behav,2012,36(1):116-123.
[8] 陈婉珍,杨敬,王国敬,等.创新扩散理论在推广预防出生缺陷知识及技术中的应用[J].中华医院管理杂志,2012,28(5):380-383.
[9] 段哲哲,周义程.创新扩散时间形态的S型曲线研究——要义、由来、成因与未来研究方向[J].科技进步与对策,2018,35(8):155-160.
[10] 邢洁,朱笕青,于爱军,等. 浙江省高危HPV基因型分布热力图分析[J]. 预防医学,2019,31(8):851-853.
[11] 郭冬丽,王赞宏.影响人乳头瘤病毒疫苗接种相关因素研究进展[J/CD]. 中华临床医师杂志(电子版),2017,11(13):1997-2001.
[12] 张佳莹,韩颖,王瑞杰,等.不同人群对人乳头瘤病毒及HPV疫苗的知信行调查研究[J].中国健康教育,2020,36(2):147-152.
[13] 蔡抒璇,陆毅,周闻宇.南京市女性人乳头瘤病毒疫苗认知水平及市场细分研究[J].中国医药科学,2020,10(20):10-14,24.
[14] 孟凡莉,宋凤斌,叶佳瑶,等.杭州女大学生人乳头瘤病毒及疫苗认知与接种意愿[J].中国学校卫生,2020,41(11):1737-1741.
[15] 金孔军,周悦,葛学娣. 大学生人群HPV疫苗认知及影响因素研究进展[J]. 预防医学,2019,31(5):470-473.
[16] 李莹莹. 社区慢性病管理中的医疗意见领袖识别及介入可行性研究——基于社区高血压患者网络视角[D].武汉:华中科技大学,2016.
[1] 张超, 罗小福, 刘艳, 沈建勇, 徐秦儿, 韩利萍, 马力. 湖州市老年人接种流感灭活疫苗疑似预防接种异常反应监测结果[J]. 预防医学, 2023, 35(8): 701-704.
[2] 李改芳, 冯勤梅, 仇丽霞. 基于技术接受与使用统一理论2的妇科门诊就诊患者HPV疫苗接种行为研究[J]. 预防医学, 2023, 35(4): 295-297,326.
[3] 钱晓萍, 罗小福, 凌健. 湖州市疫苗接种相关的过敏性皮疹监测结果[J]. 预防医学, 2023, 35(4): 339-341.
[4] 窦倩如, 黄翠敏, 曹霞, 樊利春. 海南省女性HPV疫苗相关知识和接种意愿调查[J]. 预防医学, 2023, 35(4): 359-364.
[5] 王炸亚, 叶莉霞, 吴锋. 宁波市2018—2021年出生儿童肠道病毒71型疫苗接种情况分析[J]. 预防医学, 2023, 35(10): 895-898.
[6] 何飞, 马永法, 顾春艳, 潘铭, 陈万庚. 2005—2021年盐都区水痘流行特征[J]. 预防医学, 2023, 35(1): 61-64.
[7] 江伟, 刘艳, 杜渐, 许玉洋, 车鑫仁, 王婧, 王骏, 张学潮, 顾雯雯, 张小平. 2017—2021年杭州市HPV疫苗疑似预防接种异常反应监测结果[J]. 预防医学, 2023, 35(1): 71-73,77.
[8] 张超, 沈建勇, 罗小福, 徐秦儿, 韩利萍. 2015—2021年湖州市MMR疫苗疑似预防接种异常反应监测结果[J]. 预防医学, 2023, 35(1): 74-77.
[9] 龚震宇, 龚训良. 全球消除脊髓灰质炎进展[J]. 预防医学, 2022, 34(8): 861-862.
[10] . 系统性红斑狼疮患者疫苗接种专家共识[J]. 预防医学, 2022, 34(12): 1189-1193.
[11] 王晓柳, 汤元妃. 2018—2021年武义县疑似预防接种异常反应监测结果[J]. 预防医学, 2022, 34(11): 1167-1171,1177.
[12] 孙秀, 张六仁, 陈涛, 毛升, 周怡, 吴玥, 魏征, 傅传喜. 基于防范行为采纳模型的女大学生HPV疫苗犹豫干预研究[J]. 预防医学, 2022, 34(1): 22-26.
[13] 孙肖瑜, 郑晓春, 魏晶娇, 陈玲萍, 王志刚, 李万仓, 王婵敏. 2016—2020年温州市流行性乙型脑炎流行特征分析[J]. 预防医学, 2021, 33(9): 919-920.
[14] 林越东, 李峤, 覃青连, 颜星星, 成曼, 周红霞, 唐咸艳. 广西某医学院校女大学生接种HPV 疫苗知识、信念和行为调查[J]. 预防医学, 2021, 33(9): 955-957.
[15] 龚震宇, 龚训良. 世界卫生组织关于在社区暴发环境下接种肺炎球菌结合疫苗的附加意见书(摘译)[J]. 预防医学, 2021, 33(7): 755-756.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed